Asgard Therapeutics receives €2.5M grant from European Innovation Council Accelerator to advance cancer immunotherapy program.
Amount Raised
€2.5 Million
Round Type
Grant
Investors
Description
Asgard Therapeutics, a Lund, Sweden-based biotech company, received a €2.5M grant from the European Innovation Council (EIC) Accelerator. The company will use the funds to accelerate preparatory work for its lead program, AT-108, advancing toward First-in-Human clinical trials in 2027. Asgard develops gene therapy products using direct cell reprogramming technologies to trigger personalized anti-cancer immune responses. The platform uses a replication-deficient adenoviral vector to reprogram tumor cells into antigen-presenting dendritic-like cells.
Quick answer
Asgard Therapeutics raised €2.5 Million in a Grant round, dated November 20, 2026. Investors: European Innovation Council Accelerator. Asgard Therapeutics is based in Lund, Skåne County, Sweden.
- How much did Asgard Therapeutics raise?
- Asgard Therapeutics raised €2.5 Million in a Grant round on November 20, 2026.
- Who invested in Asgard Therapeutics?
- European Innovation Council Accelerator is named as investors in this round.
- What does Asgard Therapeutics do?
- Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies.
- Where is Asgard Therapeutics based and how big is it?
- Asgard Therapeutics is based in Lund, Skåne County, Sweden. Fundz records about 29 employees.
- Who are the decision-makers at Asgard Therapeutics?
- Fundz holds 3 contacts at Asgard Therapeutics, including the Vice President, Head of Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Financial Services and Biotechnology around the same time
Companies in the same sectors as Asgard Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- DawaDose raised an undisclosed amount (Seed) on November 19, 2026.
- Insight Molecular Diagnostics Inc. raised $15M (Post-IPO Equity) on November 18, 2026.
- ChronoScale Holdings Corp raised $153M (Series C) on November 18, 2026.
- NEXGEL raised $2M (Post-IPO Equity) on November 18, 2026.
- Commit Biologics raised $60M (Seed) on November 17, 2026.
- Onward Therapeutics SA raised $28M (Series B) on November 17, 2026.
Who to call at Asgard Therapeutics, and when
A new round usually means Asgard Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Asgard Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Asgard Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Asgard Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Asgard Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Asgard Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.